We are live on ! Find out more
FP

Flagship Pioneering Portfolio holdings

AUM $1.16B
1-Year Est. Return 67.93%
This Fund
S&P 500
This Quarter Est. Return
-33.41%
1 Year Est. Return
+67.93%
3 Year Est. Return
-39.17%
5 Year Est. Return
-45.89%
10 Year Est. Return
–
AUM
$4.26B
AUM Growth
-$2.21B
Cap. Flow
+$12.6M
Cap. Flow %
0.3%
Top 10 Hldgs %
99.18%
Holding
13
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AXLA
Axcella Health Inc. Common Stock
AXLA
+$12.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
1
Moderna
MRNA
$21.5B
$3.03B 71.11%
17,581,016
– –
SANA icon
2
Sana Biotechnology
SANA
$885M
$283M 6.64%
34,239,018
– –
RUBY
3
DELISTED
Rubius Therapeutics, Inc
RUBY
$212M 4.98%
38,506,526
– –
FHTX icon
4
Foghorn Therapeutics
FHTX
$285M
$193M 4.53%
12,674,120
– –
OMGA
5
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$162M 3.8%
25,902,269
– –
MCRB icon
6
Seres Therapeutics
MCRB
$48.1M
$102M 2.4%
718,940
– –
DNLI icon
7
Denali Therapeutics
DNLI
$3.67B
$84.3M 1.98%
2,619,968
– –
EVLO
8
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$78.1M 1.83%
1,151,503
– –
AXLA
9
DELISTED
Axcella Health Inc. Common Stock
AXLA
$48.5M 1.14%
754,711
+252,774
+50% +$12.6M
KLDO
10
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$32.3M 0.76%
19,575,710
– –
CDAK
11
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$16.3M 0.38%
2,607,303
– –
SGTX
12
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$15.2M 0.36%
797,721
– –
SYRS
13
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$3.5M 0.08%
293,849
– –

Similar funds

AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
BI
Bramshill Investments Naples, Florida $1.16B AUM 0.86% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
SFG
SNS Financial Group Minneapolis, Minnesota $1.16B AUM 13.88% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
FFP
FourThought Financial Partners Venice, Florida $1.16B AUM 24.95% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Flagship Pioneering's Q1 2022 Portfolio in Review

As of Q1 2022, Flagship Pioneering held 13 positions worth $4.26B, down 34% from $6.47B the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 0%. Flagship Pioneering opened no new positions and made no exits, leaving the 13-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Flagship Pioneering added most to Axcella Health Inc. Common Stock in Q1 2022, an estimated $12.6M increase.
  • Flagship Pioneering's ten largest holdings make up 99% of its $4.26B portfolio in Q1 2022.
  • Flagship Pioneering opened 0 new positions and closed 0 in Q1 2022.
  • Flagship Pioneering's portfolio value fell 34% quarter-over-quarter to $4.26B.

Based on Flagship Pioneering's 13F filing for Q1 2022, filed 16 May 2022.